Niclosamide is a Negative Allosteric Modulator of Group I Metabotropic Glutamate Receptors: Implications for Neuropathic Pain

被引:0
作者
Ni Ai
Richard D. Wood
Eric Yang
William J. Welsh
机构
[1] Zhejiang University,Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences
[2] Snowdon,Department of Pharmacology, Rutgers
[3] Inc.,Robert Wood Johnson Medical School
[4] Rutgers University,undefined
来源
Pharmaceutical Research | 2016年 / 33卷
关键词
group I metabotropic glutamate receptors; neuropathic pain; niclosamide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3044 / 3056
页数:12
相关论文
共 147 条
[1]  
Treede RD(2008)Neuropathic pain: redefinition and a grading system for clinical and research purposes Neurology 70 1630-1635
[2]  
Jensen TS(2008)Prevalence of chronic pain with neuropathic characteristics in the general population Pain 136 380-387
[3]  
Campbell JN(2013)The glutamatergic system as a target for neuropathic pain relief Exp Physiol 98 372-384
[4]  
Cruccu G(2000)Peripheral neuropathic pain: from mechanisms to symptoms Clin J Pain 16 S12-S20
[5]  
Dostrovsky JO(2003)Translation of symptoms and signs into mechanisms in neuropathic pain Pain 102 1-8
[6]  
Griffin JW(2001)Glutamate receptors and nociception: implications for the drug treatment of pain CNS Drugs 15 29-58
[7]  
Bouhassira D(2002)Allosteric binding sites on cell-surface receptors: novel targets for drug discovery Nat Rev Drug Discov 1 198-210
[8]  
Lanteri-Minet M(1965)On the nature of allosteric transitions: a plausible model J Mol Biol 12 88-118
[9]  
Attal N(2014)Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders Nat Rev Drug Discov 13 692-708
[10]  
Laurent B(2010)Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery Pharmacol Rev 62 265-304